HF
IVA

HRT Financial’s Inventiva IVA Stock Holding History

HRT Financial’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Buy
+18,854
New +$115K ﹤0.01% 3350

Other funds holding IVA

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

HRT Financial's IVA Position: Q1 2026 in Review

HRT Financial opened a new position in Inventiva (IVA) in Q1 2026: 18,854 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #3350 among its holdings.

65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

  • HRT Financial held 18,854 shares of Inventiva worth $104K as of Q1 2026.
  • Inventiva was a new HRT Financial position in Q1 2026.
  • Inventiva made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3350 holding.
  • 65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.